Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ONABOTULINUMTOXINA Cause Injection site rash? 329 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 329 reports of Injection site rash have been filed in association with ONABOTULINUMTOXINA. This represents 0.7% of all adverse event reports for ONABOTULINUMTOXINA.

329
Reports of Injection site rash with ONABOTULINUMTOXINA
0.7%
of all ONABOTULINUMTOXINA reports
0
Deaths
4
Hospitalizations

How Dangerous Is Injection site rash From ONABOTULINUMTOXINA?

Of the 329 reports, 4 (1.2%) required hospitalization.

Is Injection site rash Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ONABOTULINUMTOXINA. However, 329 reports have been filed with the FAERS database.

What Other Side Effects Does ONABOTULINUMTOXINA Cause?

Drug ineffective (18,179) Off label use (9,698) Product preparation error (3,593) Multiple use of single-use product (2,781) Therapeutic response decreased (2,685) Headache (2,316) Injection site pain (2,143) Eyelid ptosis (1,853) Wrong technique in product usage process (1,477) Migraine (1,232)

What Other Drugs Cause Injection site rash?

ETANERCEPT (3,781) DUPILUMAB (3,566) ADALIMUMAB (2,108) TIRZEPATIDE (1,131) IXEKIZUMAB (526) DULAGLUTIDE (501) EVOLOCUMAB (465) TERIPARATIDE (426) SARILUMAB (424) HYDROXYPROGESTERONE CAPROATE (384)

Which ONABOTULINUMTOXINA Alternatives Have Lower Injection site rash Risk?

ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC-XIOI ONABOTULINUMTOXINA vs ONBREZ ONABOTULINUMTOXINA vs ONDANSETRON ONABOTULINUMTOXINA vs ONFI

Related Pages

ONABOTULINUMTOXINA Full Profile All Injection site rash Reports All Drugs Causing Injection site rash ONABOTULINUMTOXINA Demographics